Biotinylated Human IL-4 Protein, Avitag™,His Tag
Proteins and Peptides
- 貨號 Cat. No.
- IL4-H82E0
- 規格 Size
- 200ug
- 品牌 Brand
- ACROBiosystems
- Species
- Human
- Conjugate
- Precision Avi
- Expression System
- HEK293
- Tag
- Avi Tag 、 His Tag
Description
Source :
Biotinylated Human IL-4, Avitag,His Tag (IL4-H82E0) is expressed from human 293 cells (HEK293). It contains AA His 25 - Ser 153 (Accession # AAH67514).
Molecule : IL-4
Synonyms : IL4,BCGF1,BSF1
Format : Powder
Category : MABSol® Biotin Labeled Proteins
Accession : AAH67514
Storage : -20℃
Shipping condition : Powder,RT
Molecular Weight : 17.6 kDa
Characteristics :
This protein carries an Avi tag (Avitag™) at the C-terminus, followed by a polyhistidine tag. The protein has a calculated MW of 17.6 kDa. As a result of glycosylation, the protein migrates as 22 kDa under reducing (R) condition, and 21 kDa under non-redu
Endotoxin Level : Less than 1.0 EU per μg by the LAL method.
Buffer : PBS, pH7.4
Description :
Interleukin-4, is a cytokine that induces differentiation of naive helper T cells (Th0 cells to Th2 cells). In the presence of IL-4 and IL-13, cytokines that are produced in a Th-2 type response, particularly during allergy and parasitic infections, macrophages become differentially activated, And this cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. Recently, researcher found that the cytokine IL-4 plays a key role in development of innate CD8+ T cells in the thymus of several gene-deficient mouse strains, including Itk, KLF2, CBP and Id3, without previous exposure to antigen.
References :
(1) Callard RE., et al., 1991, Br J Haematol. Jul;78(3):293-9.
(2) Varin A, Gordon S., et al., 2009, Immunobiology. 214(7):630-41.
(3) Finkelman FD, et al., 2004, Immunol Rev. 201:139-55.
(4) Lee YJ, Jameson SC,et al., 2011, Trends Immunol. 32(2):50-6. Epub 2011 Feb 1.

